Lin, Y., Deng, Q., Wang, Y., Fu, X., Ma, J., & Li, W. (2015). Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy. Med Sci Monit.
Citação norma ChicagoLin, Ying-Li, Qiu-Kui Deng, Yu-Hao Wang, Xing-Li Fu, Jian-Guo Ma, and Wen-Ping Li. "Aberrant Protocadherin17 (PCDH17) Methylation in Serum Is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy." Med Sci Monit 2015.
ציטוט MLALin, Ying-Li, et al. "Aberrant Protocadherin17 (PCDH17) Methylation in Serum Is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy." Med Sci Monit 2015.